LAB STANDARD BIOTOOLS INC.: institutional ownership and insider trading
150 funds reported holding $268M of STANDARD BIOTOOLS INC. in their latest 13F filings; in Q2 2026 funds net sold $741K, with 40 new positions and 51 funds selling out; over the last 12 months insiders bought $14.4M and sold $0 on the open market.
Famous investors holding LAB
- Andreas Halvorsen (Viking Global Investors): $48.3M, 0.1% of the portfolio
- Izzy Englander (Millennium Management): $2.89M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $2.32M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.96M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $816K, 0.0% of the portfolio
Largest institutional holders of LAB
- Casdin Capital, LLC — $73.0M
- VIKING GLOBAL INVESTORS LP — $48.3M
- MAK CAPITAL ONE LLC — $23.7M
- VANGUARD GROUP INC — $22.1M
- Long Focus Capital Management, LLC — $19.3M
- VANGUARD CAPITAL MANAGEMENT LLC — $10.1M
- BlackRock, Inc. (BLK) — $6.79M
- Hollow Brook Wealth Management LLC — $4.53M
- Neuberger Berman Group LLC — $4.04M
- Qube Research & Technologies Ltd — $3.97M
Recent LAB insider trades
- Dec 4, 2025: Casdin Partners GP, LLC bought 350,000 shares ($503K)
- Nov 25, 2025: Casdin Partners GP, LLC bought 7,700,000 shares ($10.0M)
- Nov 20, 2025: Casdin Partners GP, LLC bought 1,075,000 shares ($1.37M)
- Nov 17, 2025: Casdin Partners GP, LLC bought 925,000 shares ($1.12M)
5%+ owners
- Eli Casdin: 23.9% (Schedule 13D/A, filed Jun 9, 2026)
- VIKING GLOBAL INVESTORS LP: 15.0% (Schedule 13D, filed Jun 12, 2026)
- MAK CAPITAL ONE LLC: 7.3% (Schedule 13G/A, filed Aug 14, 2026)
- MAK Capital Fund LP: 6.7% (Schedule 13G/A, filed May 15, 2026)
- LONG FOCUS CAPITAL MANAGEMENT, LLC: 6.0% (Schedule 13G, filed Aug 14, 2026)